R&D deductions, corporate guarantee pricing and business loss claims largely upheld; delayed ESIC contribution remained disallowable.

Corporate guarantee fee adjustment and interest disallowance under section 36(1)(iii) were deleted where earlier coordinate-bench rulings covered identical facts and the advances were treated as business-linked. Weighted deduction claims for R&D expenditure, product registration expenses and additional section 35(2AB) deduction on gross R&D spend were allowed, while delayed ESIC employees' contribution was disallowed under the statutory due-date rule. Section 14A disallowance was restricted, foreign currency loss was treated as business loss, cash salary disallowance was deleted, and bad debts, gratuity under section 43B, depreciation verification and the section 115JB adjustment were decided substantially in the assessee's favour. Freebies to doctors were disallowed and the section 80IB allocation was rejected.

---

---

Issues: (i) Whether the transfer pricing adjustment on corporate guarantee fee and the disallowance of interest under section 36(1)(iii) were sustainable; (ii) Whether the disallowance concerning weighted deduction on R&D expenditure and product registration expenses was justified; (iii) Whether the disallowances concerning section 14A, withdrawal of suo motu disallowance, foreign currency loss and cash salary payments were sustainable; (iv) Whether the disallowance of freebies to doctors, bad debts, deduction under section 80IB, gratuity under section 43B, depreciation claim and adjustment under section 115JB were sustainable; (v) Whether the assessee was entitled to additional weighted deduction under section 35(2AB) on gross R&D expenditure and whether the delayed ESIC contribution was allowable.

Issue (i): Whether the transfer pricing adjustment on corporate guarantee fee and the disallowance of interest under section 36(1)(iii) were sustainable.

Analysis: The corporate guarantee adjustment was found to be covered by earlier co-ordinate bench decisions on identical facts, with no distinguishing feature shown by the Revenue. The interest disallowance was also held to be unsustainable because the advances were treated as business-linked strategic advances and no contrary factual distinction was demonstrated for the year under appeal.

Conclusion: The transfer pricing adjustment and the interest disallowance were deleted, in favour of the assessee.

Issue (ii): Whether the disallowance concerning weighted deduction on R&D expenditure and product registration expenses was justified.

Analysis: The R&D-related disallowance was considered on the basis that the factual matrix was identical to earlier years and that the expenditure had been approved in the relevant R&D framework. Product registration expenses were treated as revenue in nature and were held to be allowable on the strength of earlier binding precedent on similar foreign registration and business-expansion expenditure.

Conclusion: The disallowances were deleted, in favour of the assessee.

Issue (iii): Whether the disallowances concerning section 14A, withdrawal of suo motu disallowance, foreign currency loss and cash salary payments were sustainable.

Analysis: The section 14A adjustment was restricted after examining the assessee's own computation and the related claim. The withdrawal of suo motu disallowance was accepted because the claim was already reflected in the return and the appellate authority relied on the existing record. The foreign currency loss was treated as a business loss arising from hedging-linked export exposure and not as a speculative loss. The cash salary disallowance was deleted because the evidence showed genuine business expenditure and no statutory violation was established.

Conclusion: These disallowances were not sustained, except that the record reflects only the restricted disallowance under section 14A as upheld by the appellate authority, which remained in favour of the assessee.

Issue (iv): Whether the disallowance of freebies to doctors, bad debts, deduction under section 80IB, gratuity under section 43B, depreciation claim and adjustment under section 115JB were sustainable.

Analysis: The claim for freebies to doctors failed in view of the prohibition on such expenditure and the statutory bar under the expense-disallowance framework. The bad debt claim was allowed because the amount had been actually written off during the year. The allocation of R&D expenditure to the eligible 80IB unit was rejected as an ad hoc apportionment without nexus. Gratuity was allowed under section 43B on the basis of existing records and payment details. The depreciation issue was directed to be verified and allowed accordingly, while the MAT adjustment under section 115JB was deleted because the relevant expenditure adjustment was not justified on the facts.

Conclusion: The freebies disallowance was upheld against the assessee, while the bad debt claim, section 80IB claim, gratuity claim, depreciation issue and section 115JB adjustment were decided in favour of the assessee, with depreciation remitted for verification.

Issue (v): Whether the assessee was entitled to additional weighted deduction under section 35(2AB) on gross R&D expenditure and whether the delayed ESIC contribution was allowable.

Analysis: The additional weighted deduction was allowed because the expenditure was held to be eligible on the gross amount and the contract research income was not required to be reduced in the manner suggested by the Revenue. The delayed ESIC contribution was disallowed in view of the binding Supreme Court position on employees' contribution paid beyond the due date.

Conclusion: The additional weighted deduction was allowed in favour of the assessee, while the delayed ESIC contribution was disallowed against the assessee.

Final Conclusion: The Revenue's appeal was dismissed on most substantive issues and the assessee succeeded on its main claim for additional R&D deduction, though the Revenue succeeded on the freebies issue and the assessee's delayed ESIC claim failed. The matter thus ended with mixed relief, predominantly in favour of the assessee.

Ratio Decidendi: Where an expenditure is shown to be business-linked and identical facts are already covered by earlier coordinate-bench decisions, the adjustment cannot be sustained without a distinguishing feature; similarly, eligible R&D deduction is to be granted on the actual qualifying expenditure, while delayed employees' contribution remains disallowable beyond the statutory due date.

---